机译:Real-world safety and effectiveness of retreatment of Egyptian chronic hepatitis C patients not responding to NS5A inhibitor-based therapies
Zagazig Viral Hepatitis Treatment Ctr, Gastroenterol & Hepatol, Sharkia, Egypt;
Zagazig Univ, Internal Med Dept, Sharkia, Egypt;
Zagazig Univ, Fac Med, Sharkia, EgyptAl Ahrar Educ Hosp, Gastroenterol & Hepatol Unit, Sharkia, Egypt;
chronic hepatitis C; direct-acting antivirals; hepatocellular carcinoma; NS5A inhibitor; sustained virologic response;